Saxagliptin in Patients With Type 2 Diabetes and Acute Myocardial Infarction:Effects on Platelet Function
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 20 Feb 2017 Status changed from not yet recruiting to recruiting.
- 27 Oct 2016 Planned initiation date changed from 1 Mar 2016 to 1 Dec 2016.